BIO-tract Awarded Third Patent

December 16, 2008

Nutraceutix (Redmond, WA) received a patent for BIO-tract from the Australian Patent Office. BIO-tract tablets form a protective layer in the body, shielding probiotic organisms from the acidic conditions of the stomach. After passing from the stomach to the intestinal tract, the tablets release the organisms at rates determined by formulation.

Nutraceutix (Redmond, WA) received a patent for BIO-tract from the Australian Patent Office. BIO-tract tablets form a protective layer in the body, shielding probiotic organisms from the acidic conditions of the stomach. After passing from the stomach to the intestinal tract, the tablets release the organisms at rates determined by formulation.

“Many years ago, we recognized the need for an effective probiotic and nutraceutical delivery technology-one that draws from proven pharmaceutical principals, but does so in a fashion that is economically feasible in the nutritional supplement marketplace. With BIO-tract, we have addressed this need," said Steve Moger, president of Nutraceutix.
In the case of probiotics, three barriers must be fulfilled:

1) Survival of these beneficial, but fragile organisms through the manufacturing process.
2) Survival on the store shelf.
3) Safe passage through the harsh stomach acids that may denature the organisms.
This is BIO-tract’s third international patent.

Related Content:

Delivery Systems